ACTRN12623000287639终止2 期
A randomised placebo-controlled trial investigating effectiveness of two herbal combinations for short-term stress management in healthy adults
适应症
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 入组人数
- 94
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Healthy adults (18-75 years)
- •-- Any allowable prescription medication use by participants must be stable for four weeks or more prior to trial entry
- •-- Score of 13 or more on the Perceived Stress Scale (PSS-10)
排除标准
- •-- Diagnosed depression or anxiety for which person is taking medication or has ceased taking medication within the last four weeks
- •-- Diagnosed with any of the following medical conditions: cancer (if active within last 5 years and excepting skin cancer), liver or kidney disease, neurological disease
- •-- Currently unwell with acute infection or fever
- •-- Having contracted confirmed Covid-19 in the four weeks prior to enrolment
- •-- In poor general health
- •-- Taking any of the following medications: anti-depressants; any type of neuro-active medications, i.e. mood stabilisers, stimulants, anti-psychotics; warfarin or anti-coagulant medications, cyclosporin
- •-- Current use of any herbal medicine or nutrients targeted for mood, stress or mental health (eligibility of participants taking any supplements will be at discretion of enrolling practitioner)
- •-- Pregnant or breastfeeding or planning pregnancy
- •-- Allergy/sensitivity to study drugs or their formulations
研究者
相似试验
已完成
不适用
Investigating the effect of bilateral quadriceps NeuroMuscular Electrical Stimulation (NMES) on exercise capacity in patients with severe chronic obstructive pulmonary diseaseISRCTN15985261King College Hospital (UK)52
进行中（未招募）
1 期
improvement of cognitive performance after administration of fampridina in patients with multiple sclerosisMedDRA version: 20.0Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMULTIPLE SCLEROSISEUCTR2013-002558-64-ITdipartimento di neurologia e psichiatria123
尚未招募
不适用
A micronutrient intervention for students experiencing stressAnxietyACTRN12620000551998niversity of Canterbury, School of Psychology, Speech, and Hearing120
已完成
不适用
The Neurocognitive effects of Lacprodan(Registered Trademark) PL-20 in elderly participants with age-associated memory impairment.Age-associated Memory Impairment (AAMI)Mental Health - Studies of normal psychology, cognitive function and behaviourACTRN12613000347763Swinburne University of Technology138
终止
不适用
A randomised placebo-controlled trial examining the efficacy and safety of an adjunct herbal medicine formulation in patients with major depressive disorder and poor response to anti-depressant therapyDepressionAnxietyACTRN12622000777796Integria Healthcare (Australia) Pty. Ltd.96